Capstone Quarterly Cash Flow Statement
NASDAQ: CAPSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.44-0.145 (-9.15%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Capstone free cash flow
In the quarter ended Sep 30, 2026, Capstone generated $461,000 of operating cash flow and spent $40,000 on capital expenditures. That left free cash flow of $421,000, a free-cash-flow margin of 2.1% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Capstone cash flow statement (quarterly)
| Quarter (USD) | Q3 20262026-09-30 | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q2 20192019-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -632.00K | -1.38M | -1.92M | -16.79M | -2.01M | -700.00K | -1.73M | -1.10M | 34.00K | -381.00K | -1.11M | -668.00K |
| Net Income growth (YoY) | — | — | — | — | -6023.53% | — | — | — | — | -199.74% | — | -152.27% |
| Depreciation & Amortization | 142.00K | 163.00K | 161.00K | 43.00K | 118.00K | 114.00K | 116.00K | -56.00K | 125.00K | 121.00K | 120.00K | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — | — | — | — | 3.00K |
| Change in Working Capital | 151.00K | 1.22M | -1.27M | 249.00K | 683.00K | -255.00K | 1.21M | 18.00K | -682.00K | -320.00K | 2.18M | 167.00K |
| Operating Cash Flow | 461.00K | -390.00K | -2.79M | -420.00K | 0 | -1.72M | -2.27M | 2.73M | 2.22M | 107.00K | -1.24M | -787.00K |
| Capital Expenditures | -40.00K | -64.00K | -29.00K | -120.00K | 0 | 15.00K | -17.00K | -19.00K | 20.00K | -21.00K | -100.00K | — |
| Investing Cash Flow | -27.00K | -102.00K | -29.00K | -4.47M | -2.44M | 15.00K | -17.00K | -19.00K | 20.00K | -21.00K | -100.00K | 0 |
| Debt Issued | — | — | — | 3.25M | — | — | 199.00K | 0 | — | — | — | — |
| Debt Repaid | -215.00K | -29.00K | -6.00K | -10.00K | -65.00K | 0 | -910.00K | -250.00K | -250.00K | — | — | — |
| Financing Cash Flow | -84.00K | 302.00K | 2.51M | 4.96M | 2.40M | 737.00K | 4.02M | -2.72M | -2.23M | -116.00K | 1.32M | 0 |
| Net Change in Cash | 349.00K | -194.00K | -308.00K | -3.00K | -43.00K | -971.00K | 1.73M | -3.00K | 13.00K | -30.00K | -21.00K | — |
| Free Cash Flow | 421.00K | -454.00K | -2.82M | -540.00K | 0 | -1.71M | -2.29M | 2.71M | 2.24M | 86.00K | -1.34M | -787.00K |
This table shows 12 quarterly periods of Capstone's cash flow statement, from Q3 2026 back to Q2 2019, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CAPS's reporting calendar. What is a cash flow statement?